Literature DB >> 30165924

Novel Chemically Synthesized, Alpha-Mangostin-Loaded Nano-Particles, Enhanced Cell Death Through Multiple Pathways Against Malignant Glioma.

Songping Zheng, Jiagang Liu, Ahmad Faried, Seidu A Richard, Xiang Gao.   

Abstract

Mangostin is a hydrophobic agent with potential anticancer activity. Molecular dynamics computer simulation indicated methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) and α-mangostin (α-M) have good compatibility. The α-M-loaded nano-particles acting as an anticancer agents against growth of glioma cells were prepared by self-assembly methods. In this study, the effects of α-M-loaded nano-particles, α-M/MPEG-PLA with drug loading of 15% and a mean particle size of 32 nm, on the growth of glioma cells were examined both in vitro and in vivo. The occurrence of changes in the cell signaling molecules and expression levels of various proteins related to cell death and glioma xenograft models (i.e., zebra fish, subcutaneous-mouse and orthotopic-mouse) growth following the administration of α-M/MPEG-PLA were investigated. The novel α-M/MPEG-PLA inhibited the growth of malignant glioma cells, induced cells apoptosis with cleaved caspases expression and DNA fragmentation, along with down-regulation of anti-apoptotic molecules and up-regulation of apoptotic molecules. Furthermore, decreased proliferation as well as vascularization of the tumor in vivo models were significantly achieved. A dramatic induction of programmed cell death was found in malignant glioma cells after treatment with synthetic α-M/MPEG-PLA. These results suggest that synthetic α-M/MPEG-PLA could be a promising novel anticancer agent for performing chemotherapy against malignant glioma.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30165924     DOI: 10.1166/jbn.2018.2627

Source DB:  PubMed          Journal:  J Biomed Nanotechnol        ISSN: 1550-7033            Impact factor:   4.099


  4 in total

1.  Discovery and Mechanistic Study of a Novel Human-Stimulator-of-Interferon-Genes Agonist.

Authors:  Xiaohui Zhang; Bowei Liu; Liudi Tang; Qing Su; Nicky Hwang; Mohit Sehgal; Junjun Cheng; Julia Ma; Xuexiang Zhang; Yinfei Tan; Yan Zhou; Zhongping Duan; Victor R DeFilippis; Usha Viswanathan; John Kulp; Yanming Du; Ju-Tao Guo; Jinhong Chang
Journal:  ACS Infect Dis       Date:  2019-05-14       Impact factor: 5.084

Review 2.  Nanodelivery of STING agonists against cancer and infectious diseases.

Authors:  Jiarong Zhou; Christian J Ventura; Ronnie H Fang; Liangfang Zhang
Journal:  Mol Aspects Med       Date:  2021-08-02

3.  Synergetic therapy of glioma mediated by a dual delivery system loading α-mangostin and doxorubicin through cell cycle arrest and apoptotic pathways.

Authors:  Wen Nie; Xin Zan; Ting Yu; Mengni Ran; Zehua Hong; Yihong He; Tingting Yang; Yan Ju; Xiang Gao
Journal:  Cell Death Dis       Date:  2020-10-28       Impact factor: 8.469

Review 4.  Nanoformulations of α-Mangostin for Cancer Drug Delivery System.

Authors:  Lisna Meylina; Muchtaridi Muchtaridi; I Made Joni; Ahmed Fouad Abdelwahab Mohammed; Nasrul Wathoni
Journal:  Pharmaceutics       Date:  2021-11-24       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.